Form EFFECT XORTX Therapeutics Inc.

November 26, 2024 6:04 AM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 25, 2024 4:30 P.M.
Form: F-1
CIK: 0001729214
Company Name: XORTX Therapeutics Inc.
File Number: 333-283275


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings